Boston Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$368K Sell
2,870
-24,417
-89% -$3.13M 0.02% 493
2019
Q2
$3.89M Sell
27,287
-15,392
-36% -$2.19M 0.21% 135
2019
Q1
$6.1M Buy
42,679
+36,651
+608% +$5.24M 0.31% 89
2018
Q4
$747K Sell
6,028
-4,795
-44% -$594K 0.04% 385
2018
Q3
$1.82M Buy
10,823
+2,400
+28% +$404K 0.08% 295
2018
Q2
$1.45M Buy
8,423
+5,433
+182% +$936K 0.04% 310
2018
Q1
$451K Sell
2,990
-250
-8% -$37.7K 0.01% 513
2017
Q4
$436K Sell
3,240
-300
-8% -$40.4K 0.01% 519
2017
Q3
$518K Hold
3,540
0.01% 488
2017
Q2
$550K Sell
3,540
-50
-1% -$7.77K 0.01% 468
2017
Q1
$521K Sell
3,590
-950
-21% -$138K 0.01% 455
2016
Q4
$495K Sell
4,540
-72,953
-94% -$7.95M 0.01% 481
2016
Q3
$9.41M Sell
77,493
-83,825
-52% -$10.2M 0.23% 135
2016
Q2
$22.8M Buy
161,318
+133,038
+470% +$18.8M 0.57% 41
2016
Q1
$3.69M Buy
28,280
+1,735
+7% +$227K 0.09% 220
2015
Q4
$3.73M Sell
26,545
-6,650
-20% -$935K 0.09% 228
2015
Q3
$4.41M Sell
33,195
-10,220
-24% -$1.36M 0.17% 185
2015
Q2
$7.64M Sell
43,415
-1,195
-3% -$210K 0.32% 101
2015
Q1
$7.71M Sell
44,610
-660
-1% -$114K 0.3% 106
2014
Q4
$7.41M Buy
45,270
+8,735
+24% +$1.43M 0.31% 97
2014
Q3
$5.87M Sell
36,535
-8,175
-18% -$1.31M 0.25% 118
2014
Q2
$6.57M Buy
44,710
+1,360
+3% +$200K 0.28% 104
2014
Q1
$6.01M Sell
43,350
-26,071
-38% -$3.62M 0.27% 107
2013
Q4
$8.79M Sell
69,421
-7,509
-10% -$950K 0.42% 81
2013
Q3
$7.08M Buy
76,930
+36,340
+90% +$3.34M 0.38% 87
2013
Q2
$2.79M Buy
+40,590
New +$2.79M 0.13% 138